Top Markets
#1 Islamic Coin Islamic Coin +151.32%
#2 Akedo Akedo +76.22%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.30%
#5 Velvet Velvet +34.72%
#6 Black Phoenix Black Phoenix +34.06%
#7 Cross Cross +32.03%
#8 Cap Cap +22.74%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.58%
#10 DoubleZero DoubleZero +14.87%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
H-CYTE, Inc. H-CYTE, Inc.

H-CYTE, Inc.

HCYT
Clasificación en acciones #39158
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Precio por acción
$0.995
Última sincronización: 2023-07-07
Capitalización bursátil
$624.98K
Cambio (1 día)
-0.50%
Cambio (1 año)
0.00%
País
US
Comercio H-CYTE, Inc. (HCYT)

Categoría

Healthcare
Ratio P/B de H-CYTE, Inc. (HCYT)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de H-CYTE, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de H-CYTE, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE